Brain Over Bladder: A Systematic Review of Dual Cholinesterase Inhibitor and Urinary Anticholinergic Use
- 19 January 2018
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 35 (1) , 27-41
Abstract
Case reports have demonstrated that dual use of cholinesterase inhibitors (ChIs) and urinary anticholinergics (UAChs) in older adults may be associated with delusions, aggression, changes in cognition, and anxiety, which typically resolve on drug discontinuation. Despite opposing mechanisms of action, these drugs continue to be co-prescribed.Keywords
This publication has 27 references indexed in Scilit:
- Comedication and Treatment Length in Users of Acetylcholinesterase InhibitorsDementia and Geriatric Cognitive Disorders Extra, 2017
- Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's DiseaseNeurotherapeutics, 2017
- Use of Bladder Antimuscarinics in Older Adults with Impaired CognitionJournal of the American Geriatrics Society, 2016
- Management of LUTS in patients with dementia and associated disordersNeurourology and Urodynamics, 2015
- Concomitant Use of Acetylcholine Esterase Inhibitors and Urinary Antispasmodics Among Finnish Community-Dwelling Persons With Alzheimer DiseaseJournal of Clinical Psychopharmacology, 2014
- Antimuscarinics for the treatment of overactive bladder: understanding the role of muscarinic subtype selectivityInternational Urogynecology Journal, 2011
- Trospium and cognition in patients with Late Onset Alzheimer DiseaseThe Journal of nutrition, health and aging, 2009
- The Concurrent Use of Anticholinergics and Cholinesterase Inhibitors: Rare Event or Common Practice?Journal of the American Geriatrics Society, 2004
- Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementiaClinical Pharmacology & Therapeutics, 2004
- Use of Anticholinergic Medications by Older Adults with DementiaJournal of the American Geriatrics Society, 2002